The potential of trace amines and their receptors for treating neurological and psychiatric diseases
- PMID: 18473983
- DOI: 10.2174/157488707779318107
The potential of trace amines and their receptors for treating neurological and psychiatric diseases
Abstract
Mining of the human genome has revealed approximately 7000 novel proteins, which could serve as potential targets for the development of novel therapeutics. Of these, approximately 2000 are predicted to be G-protein coupled receptors. Within this group of proteins, a family of 18 mammalian receptors has recently been identified that appear to exhibit selectivity toward the so-called trace amines. The trace amines are a family of endogenous compounds with strong structural similarity to classical monoamine neurotransmitters, consisting primarily of 2-phenylethylamine, m- and p-tyramine, tryptamine, m- and p-octopamine and the synephrines. The endogenous levels of these compounds are at least two orders of magnitude below those of neurotransmitters such as dopamine, noradrenaline and 5-HT. The effects of these low physiological concentrations have been difficult to demonstrate but it has been suggested that they may serve to maintain the neuronal activity of monoamine neurotransmitters within defined physiological limits. Such an effect of trace amines would make them ideal candidates for the development of novel therapeutics for a wide range of human disorders. Although the demonstration of a trace amine family of receptors has seen a resurgence of interest in these endogenous compounds, with recent articles reviewing trace amine pharmacological and physiological responses, the potential clinical utility of the trace amine receptors has not been specifically addressed. Historically, trace amines have been implicated in a diverse array of human pathologies ranging from schizophrenia to affective disorders to migraine. Recent studies have strengthened some of this historical data by linking trace amine receptor polymorphisms and mutations to distinct clinical conditions. The aim of the current article is to review the previous studies linking trace amines to human pathology in the context of the recently discovered trace amine receptors and evidence of the existence of trace amine receptor polymorphisms and mutations associated with such disorders. In addition, recent evidence linking trace amines to the development of drug dependence will be discussed.
Similar articles
-
Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators.J Neurochem. 2004 Jul;90(2):257-71. doi: 10.1111/j.1471-4159.2004.02501.x. J Neurochem. 2004. PMID: 15228583 Review.
-
The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain.Prog Neurobiol. 2006 Aug;79(5-6):223-46. doi: 10.1016/j.pneurobio.2006.07.003. Epub 2006 Sep 7. Prog Neurobiol. 2006. PMID: 16962229 Review.
-
Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors.Eur J Pharmacol. 2008 Jun 10;587(1-3):231-6. doi: 10.1016/j.ejphar.2008.03.055. Epub 2008 Apr 7. Eur J Pharmacol. 2008. PMID: 18486124
-
Trace amines: identification of a family of mammalian G protein-coupled receptors.Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):8966-71. doi: 10.1073/pnas.151105198. Epub 2001 Jul 17. Proc Natl Acad Sci U S A. 2001. PMID: 11459929 Free PMC article.
-
A renaissance in trace amines inspired by a novel GPCR family.Trends Pharmacol Sci. 2005 May;26(5):274-81. doi: 10.1016/j.tips.2005.03.007. Trends Pharmacol Sci. 2005. PMID: 15860375 Review.
Cited by
-
Trace Amine-Associated Receptors' Role in Immune System Functions.Biomedicines. 2024 Apr 18;12(4):893. doi: 10.3390/biomedicines12040893. Biomedicines. 2024. PMID: 38672247 Free PMC article. Review.
-
PRSS8, encoding prostasin, is mutated in patients with autosomal recessive ichthyosis.Hum Genet. 2023 Apr;142(4):477-482. doi: 10.1007/s00439-023-02527-3. Epub 2023 Jan 30. Hum Genet. 2023. PMID: 36715754
-
Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria.Metabolites. 2022 May 25;12(6):477. doi: 10.3390/metabo12060477. Metabolites. 2022. PMID: 35736410 Free PMC article.
-
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.Molecules. 2022 Apr 14;27(8):2520. doi: 10.3390/molecules27082520. Molecules. 2022. PMID: 35458717 Free PMC article. Review.
-
Trace amine-associated receptor 1 and drug abuse.Adv Pharmacol. 2022;93:373-401. doi: 10.1016/bs.apha.2021.10.005. Epub 2021 Nov 11. Adv Pharmacol. 2022. PMID: 35341572 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases